MIRA INFORM REPORT

Report Date :

16.05.2012

IDENTIFICATION DETAILS

Name :	LEAP PHARMA LLC

Registered Office :	4-2-1 Hatchobori Chuoku Tokyo 103-0032

Country :	Japan

Date of Incorporation :	August 2009

Com. Reg. No.:	0100-03-015398 (Tokyo-Chuoku)

Legal Form :	Limited Liability Company

Line of Business :	Import, Export, Wholesale of pharmaceuticals

No. of Employees :	01

RATING & COMMENTS

MIRA’s Rating :

RATING		STATUS	PROPOSED CREDIT LINE
11-25	Ca	Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity	Limited with full security

Status :	Moderate
Payment Behaviour :	Unknown
Litigation :	Clear

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

ECGC Country Risk Classification List – March 31^st, 2012

Country Name

Previous Rating

(31.12.2011)

Current Rating

(31.03.2012)

Japan

Risk Category	ECGC Classification
Insignificant	A1
Low	A2
Moderate	B1
High	B2
Very High	C1
Restricted	C2
Off-credit	D

Company name

LEAP PHARMA LLC

REGD NAME

Leap Pharma GK

MAIN OFFICE

4-2-1 Hatchobori Chuoku Tokyo 103-0032 JAPAN

Tel: 03-6280-4205

URL: N/A

ACTIVITIES

Import, export, wholesale of pharmaceuticals

BRANCHES

Nil

OFFICERS

MITO MINAKAWA, PRES

Yen Amount: In million Yen, unless otherwise stated

SUMMARY

FINANCES UNDETD A/SALES NOT DISCLOSED

PAYMENTS Unknown CAPITAL Yen 0.3 M

TREND UNDETD WORTH Yen 0.3 M

STARTED 2009 EMPLOYES 1

COMMENT

TRADING FIRM SPECIALIZING IN PHARMACEUTICALS.

FINANCIAL SITUATION UNDETERMINED DUE TO THE LACK OF PROVEN BUSINESS BUT SHOULD BE GOOD FOR MODERATE BUSINESS ENGGEMENTS.

HIGHLIGHTS

The subject company was established by Mito Minakawa in order to make most of her experience in the subject line of business. This is a trading firm specializing in import, export and wholesale of pharmaceuticals. The firm does not disclose any of its management & financial details and the information contained herein is based on and cited from the Registration Certificate.

FINANCIAL INFORMATION

Financial are not disclosed. The firm declined to disclose them. No other database has any information to this effect, either.

Both the financial situation and business trends are not determined due to the lack of proven business records, which the owner declined to disclose.

REGISTRATION

Date Registered: Aug 2009

Regd No.: 0100-03-015398 (Tokyo-Chuoku)

Legal Status: Limited Liability Company (Godo Kaisha)

Regd Capital: Yen 300,000.00

Major shareholders (%): Mito Minakawa (100)

Nothing detrimental is known as to her commercial morality.

OPERATION

Activities: Imports, exports and wholesales pharmaceuticals (100%)

Clients: Makers, wholesalers, consumers, other

No. of accounts: Unavailable

Domestic areas of activities: Centered in greater-Tokyo

Suppliers: Goods are imported

Payment record: Unknown

Location: Business area in Tokyo. Office premises at the caption address are leased and maintained satisfactorily.

Bank References:

Local Bank (Tokyo)

Relations: Money deposits and transfers only

FINANCES

(In Million Yen)

NOT DISCLOSED AND UNAVAILABLE

FOREIGN EXCHANGE RATES

Currency	Unit	Indian Rupees
US Dollar	1	Rs.53.84
UK Pound	1	Rs.86.72
Euro	1	Rs.69.17

INFORMATION DETAILS

Report Prepared by :

MNL

RATING EXPLANATIONS

RATING		STATUS	PROPOSED CREDIT LINE
>86	Aaa	Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums	Unlimited
71-85	Aa	Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums	Large
56-70	A	Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums	Fairly Large
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory
26-40	B	Capability to overcome financial difficulties seems comparatively below average.	Small
11-25	Ca	Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity	Limited with full security
<10	C	Absolute credit risk exists. Caution needed to be exercised	Credit not recommended
----	NB	New Business	----

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

Financial condition (40%) Ownership background (20%) Payment record (10%)

Credit history (10%) Market trend (10%) Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.